Form 4: Trupanion Director Dan Levitan Awarded 6,326 Restricted Stock Units

Dan Levitan, a director of Trupanion, Inc., was granted 6,326 restricted stock units (RSUs) on February 27, 2024, which will vest quarterly.

Summary

• On February 27, 2024, Dan Levitan, a director at Trupanion, Inc., received 6,326 restricted stock units (RSUs).
• These RSUs will vest in four equal installments.
• The vesting dates are March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.
• The vesting is contingent upon Mr. Levitan's continued service with the company through each vesting date.
• Each RSU converts into one share of Trupanion's common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests. The sentiment is moderately positive as it indicates continued investment in key personnel.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The RSUs will convert to common stock as they vest, increasing the number of outstanding shares over time.

Industry Context

Grants of restricted stock units are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Equity compensation practices vary across the industry, but RSU grants are a standard tool for incentivizing executives and directors.
• Companies like Zoetis and IDEXX Laboratories also utilize equity-based compensation to align management incentives with shareholder value.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes the director to work towards increasing shareholder value.
• The director benefits from the potential increase in the value of the stock as the RSUs vest.

Key Dates